Drug producer Kyowa Kirin helped the life sciences venture firm, a spinoff from Elan Corporation, close an oversubscribed $146m third fund.
Ireland-headquartered, life sciences-focused venture capital fund Fountain Healthcare Partners closed its Fund III at €125m ($146m) yesterday with a contribution from pharmaceutical company Kyowa Kirin.
The firm had raised approximately $132m for the fund’s first close in May 2019 and implied yesterday that Kyowa Kirin was the sole limited partner to add on to that total. The vehicle had an initial target of €100m.
Founded in 2008 when it was spun off by pharmaceutical company Elan Corporation, Fountain Healthcare Partners…
